Equity Analysis

Quarterly Results

    Jagsonpal Pharmaceuticals Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    507789
    INE048B01027
    74.4218212
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    JAGSNPHARM
    51.68
    1382.36
    EPS(TTM)
    Face Value()
    Div & Yield %:
    10.1
    5
    0.96
     
Quarters
(RupeeIcon Cr)
ParticularsJun 2024Mar 2024Dec 2023
Gross Sales70.1460.4339.55
Other Operating Income0.000.000.00
Other Income 1.521.881.73
Total Income71.6662.3041.28
Total Expenditure 69.3960.2539.71
PBIDT2.262.061.56
Interest 0.270.250.13
PBDT2.001.801.43
Depreciation0.880.900.90
Tax0.370.350.20
Fringe Benefit Tax0.000.000.00
Deferred Tax-0.09-0.190.12
Reported Profit After Tax0.840.750.21
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item0.840.750.21
EPS (Unit Curr.)0.730.650.18
EPS (Adj) (Unit Curr.)0.730.650.18
Calculated EPS (Unit Curr.)0.730.650.18
Calculated EPS (Adj) (Unit Curr.)0.730.650.18
Calculated EPS (Ann.) (Unit Curr.)2.922.610.71
Calculated EPS (Adj) (Ann.) (Unit Curr.)2.922.610.71
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity11.5011.5011.50
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)3.223.413.94
PBDTM(%)2.852.983.62
PATM(%)1.201.240.53
Dividend Per Share(Rs)0.000.000.00
Diluted EPS0.730.650.18